Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
BELLUS Health Inc | BLU | Toronto | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
10.30 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
0 | 0 | - | 7.41 - 16.24 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
- | 0 | $ 10.30 | CAD |
BELLUS Health Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
$ 1.30B | 72.68M | 72.68M | $ 21.71k | $ 0.00 | -0.90 | 304.00 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
304.37k | $ - | - | 0.00 | - |
BELLUS Health News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BLU Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 10.36 | 11.24 | 10.09 | 10.49 | 55,152 | -0.06 | -0.58% |
1 Month | 10.04 | 11.24 | 9.93 | 10.46 | 46,237 | 0.26 | 2.59% |
3 Months | 11.54 | 11.87 | 9.82 | 10.55 | 52,071 | -1.24 | -10.75% |
6 Months | 14.21 | 14.92 | 9.82 | 12.09 | 79,482 | -3.91 | -27.52% |
1 Year | 7.73 | 16.24 | 7.41 | 12.45 | 126,408 | 2.57 | 33.25% |
3 Years | 13.41 | 16.68 | 2.70 | 8.00 | 146,732 | -3.11 | -23.19% |
5 Years | 0.50 | 16.68 | 0.46 | 5.62 | 159,825 | 9.80 | 1,960.0% |
BELLUS Health Description
BELLUS Health Inc is a clinical-stage biopharmaceutical development company advancing novel therapeutics for conditions with a high unmet medical need, including BLU-5937, P2X3 antagonist that has... |